Economy of contraction of cardiomyocytes as influenced by different positive inotropic interventions

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Popping S ^a   Mruck, S ^a   Fischer, Y ^a   Kulsch, D ^a   Ionescu, I ^a   Kammermeier, H ^a   Rose, H ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

calcium; calcium sensitizer; contractility; cross bridge cycling; EMD 57033; relaxation; sensitization

Indexed keywords

5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; ISOMAZOLE; ISOPRENALINE; PIMOBENDAN; SULMAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR CALCIUM; HEART ARRHYTHMIA; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; INOTROPISM; METABOLIC REGULATION; MYOFILAMENT; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

EID: 33750812533     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.1.h357     Document Type: Article

References (44)

1. Alpert, N. R., E. M. Blanchard, and L. A. Mulieri. Tension independent heat in rabbit papillary muscle. J. Physiol. Lond. 414: 433-453, 1989.
2. Beier, N., J. Harting, R. Jonas, M. Klockow, I. Lues, and G. Häusler. The novel cardiotonic agent EMD 53998 is a potent "calcium sensitizer." J. Cardiovasc. Pharmacol. 18: 17-27, 1991.
3. Beier, N., R. Jonas, M. Klockow, I. Lues, and H. P. Wolf. The two mechanisms of action of the racemic cardiotonic EMD 53998, Ca-sensitization and PDE-inhibition, reside in different enantiomers (Abstract). J. Mol. Cell. Cardiol. 23, Suppl. V: 69, 1991.
4. Blanchard, E. M., G. L. Smith, D. G. Allen, and N. R. Alpert. The effects of 2,3-butanedione monoxime on initial beat, tension, and aequorin light output of ferret papillary muscles. Pfluegers Arch. 416: 219-221, 1990.
5. 2+-regulation of muscle contraction. Implications for physiological and pharmacological approaches to modulate contractile function of myocardium. Basic Res. Cardiol. 86, Suppl. 3: 83-92, 1991.
6. 2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers. Implications for regulation of muscle contraction. Proc. Natl. Acad. Sci. USA 85: 3265-3269, 1988.
7. Brenner, B. Muscle mechanics and biochemical kinetics. In: Molecular Mechanisms of Muscle Contraction, edited by J. Squire. London: Macmillan, 1990, p. 77-149.
8. Brutsaert, D. L., and S. U. Sys. Relaxation and diastole of the heart. Physiol. Rev. 69: 1228-1316, 1989.
9. Chiu, Y. C., K. R. Walley, and L. E. Ford. Comparison of the effects of different inotropic interventions on force, velocity, and power in rabbit myocardium. Circ. Res. 65: 1161-1171, 1989.
10. Edman, K. A. P., and F. Lou. Changes in force and stiffness induced by fatigue and intracellular acidification in frog muscle fibres. J. Physiol. Lond. 424: 133-149, 1990.
11. 2+ transient in rat myocardium. J. Mol. Cell. Cardiol. 23: 325-331, 1991.
12. Ferroni, C., H. A. Spurgeon, M. Klockow, E. G. Lakatta, and M. C. Capogrossi. Contractile potentiation without increasing cytosolic calcium in single rat ventricular myocytes. FASEB J. 3: 4720-4725, 1989.
13. Fischer, Y., H. Rose, and H. Kammermeier. Highly insulin-responsive isolated rat heart muscle cells yielded by a modified isolation method. Life Sci. 49: 1679-1688, 1991.
14. Franciosa, J. A., M. Wilen, S. Ziesche, and J. S. Cohn. Survivial in men with service left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 51: 831-836, 1992.
15. Fraticelli, A., R. Josephson, R. Danziger, E. Lakatta, and H. Spurgeon. Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H259-H265, 1989.
16. 2+-sensitizing effect of BM 14.478 on skinned cardiac fibres of guinea-pig papillary muscle. Eur. J. Pharmacol. 136: 243-246, 1987.
17. 2+ activation and the inotropic effect of pmobendan: comparison with milrinone. Circ. Res. 63: 911-922, 1988.
18. Gilbert, E. M., R. E. Hershberger, F. Watson, B. O'Connell, D. G. Renlund, and M. R. Bristow. Additivity of the effects of enoximone and dobutamine in the failing human heart (Abstract). Circulation 76, Suppl. IV: 255, 1987.
19. Gross, T., I. Lues, and J. Daut. A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle. J. Mol. Cell. Cardiol. 25: 239-244, 1993.
20. Hajjar, R. J., and J. K. Gwathmey. Calcium-sensitizing inotropic agents in the treatment of heart failure-a critical view. Cardiovasc. Drugs Ther. 5: 961-966, 1991.
21. Hasenfuss, G., C. Holubarsch, H. Just, E. Blanchard, L. A. Mulieri, and N. R. Alpert. Energetic aspects of inotropic interventions in rat myocardium. Basic. Res. Cardiol. 82: 251-259, 1987.
22. Haworth, R. A., R. Griffin, B. Saleh, A. B. Goknur, and H. A. Berkoff. Contractile function of isolated young and adult rat heart cells. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H484-H491, 1987.
23. Hülsmann, W. C., and L. E. A. De Wit. Acidosis, cardiac stunning and its prevention by oxygen. Cell. Biology International Reports 14: 311-315, 1990.
24. Huxley, A. F. Reflections on muscle. In: The Sherrington Lectures. Liverpool: University Press, 1980, XIV.
25. Katz, A. M. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 73: 184-190, 1986.
26. Katz, A. M. Role of the basic sciences in the practice of cardiology. J. Mol. Cell Cardiol. 19: 3-17, 1987.
27. 2+-sensitivity of the contractile system by MCI-154, a novel cardiotonic agent in chemically skinned fibers from the guinea pig papillary muscles. J. Pharmacol. Exp. Ther. 243: 633-638, 1987.
28. Lee, J. A., and D. G. Allen. EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle. Circ. Res. 69: 927-936, 1991.
29. Li, T., N. Sperelakis, R. E. Teneick, and R. J. Solaro. Effects of diacetyl monoxime on cardiac excitation-contraction coupling. J. Pharmacol Exp. Ther. 232: 688-695, 1985.
30. Lues, L., R. Siegel, and J. Harting. Effect of isomazole on the responsiveness to calcium of the contractile elements in skinned cardiac muscle fibres of various species. Eur. J. Pharmacol. 146: 145-153, 1988.
31. 2+ affinity by drugs. Proteins Struct. Funct. Genet. 11: 79-94, 1991.
32. 2+ activation of skinned human myocardium. Eur. J. Pharmacol. 165: 305-308, 1989.
33. Poole-Wilson, P. A., and G. A. Langer. Effect of pH on ionic exchange and function in rat and rabbit myocardium. Am. J. Physiol. 229: 570-581, 1975.
34. Rose, H., B. Birker, I. Ionescu, S. Popping, Y. Fischer, and H. Kammermeier. Negative inotropic effects of volatile anaesthetics and antiarrhytmic drugs in cardiomyocytes: analysis of contraction and energetics. Pharm. Pharmacol. Lett. 2: 16-19, 1992.
35. Rose, H., N. Schnitzler, and H. Kammermeier. Electrically stimulated cardiomyocytes: evaluation of shortening, oxygen consumption and tracer uptake. Biomed. Biochim. Acta 46: 622-627, 1987.
36. Rose, H., K. H. Strotmann, S. Pöpping, Y. Fischer, D. Kulsch, and H. Kammermeier. Simultaneous measurement of contraction and oxygen consumption in cardiac myocytes. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1329-H1334, 1991.
37. Rose, H., T. Hennecke, and H. Kammermeier. Sarcolemmal fatty acid transfer in isolated cardiomyocytes governed by albumin/membrane-lipid partition. J. Mol. Cell. Cardiol. 22: 883-892, 1990.
38. Rüegg, J. C. Towards a molecular understanding of contractility. Cardioscience 1: 163-168, 1990.
39. Rüegg, J. C., and I. Morano. Calcium-sensitivity modulation of cardiac myobrillar proteins. J. Cardiovasc. Pharmacol. 14: 20-23, 1989.
40. Rüegg, J. C., G. Pfitzer, D. Eubler, and C. Zeugner. Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-(2-(4-methosyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3-(2H)- pyridazinone. Arzneim. Forsch. Drug. Res. 34: 1736-1738, 1984.
41. Schelling, P., K. G. H. Becker, I. Lues, K. O. Minck, H. J. Schliep, H. Weygandt, and H. P. Wolf. In vivo characterization of the cardiotonic action of EMD 57033, a novel drug, increases left ventricular contractility via sensitization of myofibrils to calcium (Abstract). J. Mol. Cell. Cardiol. 23, Suppl. V: 69, 1991.
42. Scholz, H. Positive inotropic agents: different mechanisms of action. In: Cardiac Glycosides 1785-1985, edited by L. K. Erdmann and J. C. Greef. Darmstadt: Steinkopff, 1986, p. 181-188.
43. Wiggins, J. R., J. Reiser, D. F. Titzpatrick, and J. L. Bergey. Inotropic actions of diacetyl monoxime in cat ventricular muscle. J. Pharmacol. Exp. Ther. 212: 217-224, 1980.
44. Williamson, J. R., B. Safer, T. Rich, S. Schaffer, and K. Kobayashi. Effects of acidosis on myocardial contractility and metabolism. Acta Med. Scand. 587: 95-112, 1976.